Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 297

1.

Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment.

Chen PC, Cheng HC, Wang J, Wang SW, Tai HC, Lin CW, Tang CH.

Oncotarget. 2014 Mar 30;5(6):1595-608.

2.

CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway.

Chen PC, Cheng HC, Tang CH.

Carcinogenesis. 2013 Jul;34(7):1669-79. doi: 10.1093/carcin/bgt103. Epub 2013 Mar 27.

PMID:
23536580
3.

CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.

Wang SW, Liu SC, Sun HL, Huang TY, Chan CH, Yang CY, Yeh HI, Huang YL, Chou WY, Lin YM, Tang CH.

Carcinogenesis. 2015 Jan;36(1):104-14. doi: 10.1093/carcin/bgu218. Epub 2014 Oct 20.

PMID:
25330803
4.

CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin-dependent pathway.

Tzeng HE, Chen JC, Tsai CH, Kuo CC, Hsu HC, Hwang WL, Fong YC, Tang CH.

J Cell Physiol. 2011 Dec;226(12):3181-9. doi: 10.1002/jcp.22672.

PMID:
21344378
5.

Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.

Tzeng HE, Chen PC, Lin KW, Lin CY, Tsai CH, Han SM, Teng CL, Hwang WL, Wang SW, Tang CH.

Clin Sci (Lond). 2015 Jul;129(2):147-58. doi: 10.1042/CS20140390.

PMID:
25735814
6.

CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells.

Chen PC, Lin TH, Cheng HC, Tang CH.

Carcinogenesis. 2012 Apr;33(4):937-45. doi: 10.1093/carcin/bgs108. Epub 2012 Feb 16.

PMID:
22345292
7.

Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner.

Chen P, Huang Y, Bong R, Ding Y, Song N, Wang X, Song X, Luo Y.

Clin Cancer Res. 2011 Dec 1;17(23):7230-9. doi: 10.1158/1078-0432.CCR-11-1354. Epub 2011 Oct 12.

8.

In vitro evaluation of inhibitory effect of nuclear factor-kappaB activity by small interfering RNA on pro-tumor characteristics of M2-like macrophages.

Kono Y, Kawakami S, Higuchi Y, Yamashita F, Hashida M.

Biol Pharm Bull. 2014;37(1):137-44. Epub 2013 Oct 19.

9.

1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway.

Pang X, Zhang L, Lai L, Chen J, Wu Y, Yi Z, Zhang J, Qu W, Aggarwal BB, Liu M.

Carcinogenesis. 2011 Jun;32(6):904-12. doi: 10.1093/carcin/bgr052. Epub 2011 Mar 22.

10.

Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.

Pratheeshkumar P, Son YO, Budhraja A, Wang X, Ding S, Wang L, Hitron A, Lee JC, Kim D, Divya SP, Chen G, Zhang Z, Luo J, Shi X.

PLoS One. 2012;7(12):e52279. doi: 10.1371/journal.pone.0052279. Epub 2012 Dec 31.

11.

Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation.

Guo Z, Xing Z, Cheng X, Fang Z, Jiang C, Su J, Zhou Z, Xu Z, Holmberg A, Nilsson S, Liu Z.

PLoS One. 2015 May 26;10(5):e0124292. doi: 10.1371/journal.pone.0124292. eCollection 2015.

12.

Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways.

Pratheeshkumar P, Budhraja A, Son YO, Wang X, Zhang Z, Ding S, Wang L, Hitron A, Lee JC, Xu M, Chen G, Luo J, Shi X.

PLoS One. 2012;7(10):e47516. doi: 10.1371/journal.pone.0047516. Epub 2012 Oct 18.

13.

CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.

Lin L, Chen YS, Yao YD, Chen JQ, Chen JN, Huang SY, Zeng YJ, Yao HR, Zeng SH, Fu YS, Song EW.

Oncotarget. 2015 Oct 27;6(33):34758-73. doi: 10.18632/oncotarget.5325.

14.

The M2 macrophages induce autophagic vascular disorder and promote mouse sensitivity to urethane-related lung carcinogenesis.

Li GG, Guo ZZ, Ma XF, Cao N, Geng SN, Zheng YQ, Meng MJ, Lin HH, Han G, Du GJ.

Dev Comp Immunol. 2016 Jun;59:89-98. doi: 10.1016/j.dci.2016.01.010. Epub 2016 Jan 22.

PMID:
26806760
15.

Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer.

Liu L, Ge D, Ma L, Mei J, Liu S, Zhang Q, Ren F, Liao H, Pu Q, Wang T, You Z.

J Thorac Oncol. 2012 Jul;7(7):1091-100. doi: 10.1097/JTO.0b013e3182542752.

16.

Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression.

Comito G, Giannoni E, Segura CP, Barcellos-de-Souza P, Raspollini MR, Baroni G, Lanciotti M, Serni S, Chiarugi P.

Oncogene. 2014 May 8;33(19):2423-31. doi: 10.1038/onc.2013.191. Epub 2013 Jun 3.

PMID:
23728338
17.

Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.

Riddell JR, Maier P, Sass SN, Moser MT, Foster BA, Gollnick SO.

PLoS One. 2012;7(11):e50394. doi: 10.1371/journal.pone.0050394. Epub 2012 Nov 21.

18.

CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration.

Shimoyama T, Hiraoka S, Takemoto M, Koshizaka M, Tokuyama H, Tokuyama T, Watanabe A, Fujimoto M, Kawamura H, Sato S, Tsurutani Y, Saito Y, Perbal B, Koseki H, Yokote K.

Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):675-82. doi: 10.1161/ATVBAHA.110.203356. Epub 2010 Feb 5.

20.

Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate.

Joimel U, Gest C, Soria J, Pritchard LL, Alexandre J, Laurent M, Blot E, Cazin L, Vannier JP, Varin R, Li H, Soria C.

BMC Cancer. 2010 Jul 17;10:375. doi: 10.1186/1471-2407-10-375.

Supplemental Content

Support Center